[HTML][HTML] Myocardial infarction with non-obstructive coronary artery disease: MI with non-obstructive coronary disease

B Lindahl, T Baron, M Albertucci, F Prati - EuroIntervention, 2021 - ncbi.nlm.nih.gov
As a result of the increased use of coronary angiography in acute myocardial infarction in
the last two decades, myocardial infarction with non-obstructive coronary arteries (MINOCA) …

Coronary artery spasm: new insights

A Matta, F Bouisset, T Lhermusier… - Journal of …, 2020 - Wiley Online Library
Coronary artery spasm (CAS) defined by a severe reversible diffuse or focal vasoconstriction
is the most common diagnosis among INOCA (ischemia with no obstructive coronary artery …

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European …

Task Force Members, G Montalescot… - European heart …, 2013 - academic.oup.com
Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

[PDF][PDF] 2013 ESC guidelines on the management of stable coronary artery disease

R OUS - European heart journal, 2013 - legeforeningen.no
Redusert venstre ventrikkelfunksjon er en selvstendig og sterkt ugunstig prognostisk faktor.
Vurdering av venstre ventrikkelfunksjon med for eksempel ekkokardiografi anbefales utført …

[HTML][HTML] Coronary artery spasm: review and update

MJ Hung, P Hu, MY Hung - International Journal of Medical …, 2014 - ncbi.nlm.nih.gov
Coronary artery spasm (CAS), an intense vasoconstriction of coronary arteries that causes
total or subtotal vessel occlusion, plays an important role in myocardial ischemic syndromes …

[HTML][HTML] Coronary vasospastic angina: a review of the pathogenesis, diagnosis, and management

R Rehan, J Weaver, A Yong - Life, 2022 - mdpi.com
Vasospastic angina (VSA) is an under-appreciated cause of chest pain. It is characterised by
transient vasoconstriction of the coronary arteries and plays a significant role in the …

The who, what, why, when, how and where of vasospastic angina

JF Beltrame, F Crea, JC Kaski, H Ogawa, P Ong… - Circulation …, 2016 - jstage.jst.go.jp
Ischemic heart disease involves both “structural” and/or “functional” disorders of the
coronary circulation. Structural atherosclerotic coronary artery disease (CAD) is well …

Vasospastic angina: past, present, and future

Z He, X Xu, Q Zhao, H Ding, DW Wang - Pharmacology & Therapeutics, 2023 - Elsevier
Vasospastic angina (VSA) is characterized by episodes of rest angina that are responsive to
short-acting nitrates and are attributable to coronary artery vasospasm. The condition is …

Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting

T Inoue, T Kato, T Uchida, M Sakuma… - Journal of the American …, 2005 - jacc.org
Objectives: The purpose of this study was to assess local release of C-reactive protein
(CRP) from atherosclerotic plaques or the vessel wall injured by stenting. Background …

[HTML][HTML] Management of coronary artery spasm

GA Lanza, H Shimokawa - European Cardiology Review, 2023 - ncbi.nlm.nih.gov
Calcium channel blockers (CCBs) are the first-line treatment for coronary artery spasm
(CAS). When CAS-related angina symptoms are not well controlled by CCB therapy, long …